Covance
120
2
4
88
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
20.0%
24 terminated/withdrawn out of 120 trials
78.6%
-7.9% vs industry average
16%
19 trials in Phase 3/4
42%
37 of 88 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (120)
A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
Role: collaborator
Staccato Loxapine Thorough QT/QTc Study
Role: collaborator
Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion.
Role: collaborator
Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment
Role: collaborator
Mass Balance Study of KBP-5074 in Healthy Male Subjects
Role: collaborator
Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects
Role: collaborator
First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma
Role: collaborator
Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer
Role: collaborator
ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies
Role: collaborator
A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone
Role: collaborator
Study of the Gut Hormone Analogue Y14 in Adult Subjects
Role: collaborator
A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
Role: collaborator
Study to Evaluate Changes in Smokers Using on!® Nicotine Pouches
Role: collaborator
Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer
Role: collaborator
Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3
Role: collaborator
Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients
Role: collaborator
Safety, Tolerability and Pharmacokinetics of AM1476 in Healthy Subjects
Role: collaborator
Study to Evaluate Safety, Tolerability and Pharmacokinetics of rhNGF Eye Drops in Healthy Volunteers
Role: collaborator
A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)
Role: collaborator
A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)
Role: collaborator